Terms: = Leukemia AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Prognosis
20 results:
1. Key candidate genes and pathways in T lymphoblastic leukemia/lymphoma identified by bioinformatics and serological analyses.
Ren Y; Liang H; Huang Y; Miao Y; Li R; Qiang J; Wu L; Qi J; Li Y; Xia Y; Huang L; Wang S; Kong X; Zhou Y; Zhang Q; Zhu G
Front Immunol; 2024; 15():1341255. PubMed ID: 38464517
[TBL] [Abstract] [Full Text] [Related]
2. A novel stemness classification in acute myeloid leukemia by the stemness index and the identification of cancer stem cell-related biomarkers.
Huang Y; Zhang Z; Sui M; Li Y; Hu Y; Zhang H; Zhang F
Front Immunol; 2023; 14():1202825. PubMed ID: 37409118
[TBL] [Abstract] [Full Text] [Related]
3. Chemotherapeutics for Acute Erythroid leukemia: Research, Present and Future.
Liao Z; Li J; Wu J; Liu J; Sun S
Curr Mol Med; 2021; 21(10):819-831. PubMed ID: 33475071
[TBL] [Abstract] [Full Text] [Related]
4. Targeting on glycosylation of mutant FLT3 in acute myeloid leukemia.
Hu X; Chen F
Hematology; 2019 Dec; 24(1):651-660. PubMed ID: 31533545
[No Abstract] [Full Text] [Related]
5. BCR-ABL1-like B-Lymphoblastic leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use.
Yenamandra AK; Kaviany S; Borinstein SC; Friedman DL; Kovach AE
Lab Med; 2019 Oct; 50(4):401-405. PubMed ID: 30938769
[TBL] [Abstract] [Full Text] [Related]
6. Effect of NPM1 type B mutation on the proliferation, invasion and chemosensitivity of THP-1 leukemia cells.
Peng J; Fu B; Fu G; Zhao X; Li X; Chen F
Pharmazie; 2017 Oct; 72(10):608-613. PubMed ID: 29441887
[TBL] [Abstract] [Full Text] [Related]
7. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid leukemia.
Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
[TBL] [Abstract] [Full Text] [Related]
8. [Myokines - muscle tissue hormones].
Stránská Z; Svačina Š
Vnitr Lek; 2015 Apr; 61(4):365-8. PubMed ID: 25894270
[TBL] [Abstract] [Full Text] [Related]
9. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
Wang C; Chen Z; Li Z; Cen J
Leuk Res; 2010 Aug; 34(8):1083-90. PubMed ID: 20138666
[TBL] [Abstract] [Full Text] [Related]
10. [Correlation of adult AML Npm1 mutations with prognosis and its relationship with gene mutation of FLT3 and CEBPA].
Bao LY; Wang JS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):19-24. PubMed ID: 20137111
[TBL] [Abstract] [Full Text] [Related]
11. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract] [Full Text] [Related]
12. [Myelodysplastic syndromes--new treatment options].
Germing U
Med Klin (Munich); 2006 Mar; 101 Suppl 1():123-6. PubMed ID: 16802536
[TBL] [Abstract] [Full Text] [Related]
13. A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders.
Thiele J; Kvasnicka HM
Leuk Lymphoma; 2006 Mar; 47(3):381-96. PubMed ID: 16396760
[TBL] [Abstract] [Full Text] [Related]
14. DNA methylation changes in multiple myeloma.
Galm O; Wilop S; Reichelt J; Jost E; Gehbauer G; Herman JG; Osieka R
Leukemia; 2004 Oct; 18(10):1687-92. PubMed ID: 15318245
[TBL] [Abstract] [Full Text] [Related]
15. Myelodysplastic syndromes.
Miller KB
Curr Treat Options Oncol; 2000 Apr; 1(1):63-9. PubMed ID: 12057062
[TBL] [Abstract] [Full Text] [Related]
16. The impact and management of anaemia in haematological malignancies.
Coiffier B
Med Oncol; 2000 Nov; 17 Suppl 1():S2-10. PubMed ID: 11188782
[TBL] [Abstract] [Full Text] [Related]
17. Quantitative expression of erythropoietin receptor (epo-R) on acute leukaemia cells: relationships between the amount of epo-R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosis. Japan Adult Leukaemia Study Group.
Takeshita A; Shinjo K; Higuchi M; Miyawaki S; Takemoto Y; Kishimoto Y; Saito K; Takuchi H; Kuriyama K; Kimura Y; Asou N; Takahashi M; Hotta T; Kanamaru A; Ueda R; Ohno R
Br J Haematol; 2000 Jan; 108(1):55-63. PubMed ID: 10651724
[TBL] [Abstract] [Full Text] [Related]
18. Transformation of severe aplastic anemia into acute myeloblastic leukemia with monosomy 7.
Hashino S; Imamura M; Tanaka J; Kobayashi S; Musashi M; Kasai M; Asaka M
Ann Hematol; 1996 May; 72(5):337-9. PubMed ID: 8645749
[TBL] [Abstract] [Full Text] [Related]
19. [Clinical features of atypical refractory anemia (RA)].
Matsuda A; Jinnai I; Kusumoto S; Shiramatsu F; Bessho M; Saito M; Hirashima K
Rinsho Ketsueki; 1991 Aug; 32(8):855-61. PubMed ID: 1942525
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic variables in hairy cell leukemia after splenectomy as initial therapy.
Ratain MJ; Vardiman JW; Barker CM; Golomb HM
Cancer; 1988 Dec; 62(11):2420-4. PubMed ID: 3179961
[TBL] [Abstract] [Full Text] [Related]
